Sunil Babu
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies
Papers in
- Co-authors
- David Robert Spigel (2 shared papers)Jason Claud Chandler (2 shared papers)Robert M. Jotte (2 shared papers)Larry A. Greenbaum (4 shared papers)Neil Sheerin (4 shared papers)David J. Cohen (4 shared papers)David Michael Waterhouse (2 shared papers)Richard R. Furman (4 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (4 papers)Annals of Oncology (2 papers)Hematological Oncology (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Sunil Babu
46 papers receiving 6.3k citations
Sunil Babu's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 3.1k
- Nephrology 828
- Immunology 1.9k
- Transplantation 187
- Hematology 766
Countries citing papers authored by Sunil Babu
This map shows the geographic impact of Sunil Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Babu more than expected).
Fields of papers citing papers by Sunil Babu
This network shows the impact of papers produced by Sunil Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Babu. The network helps show where Sunil Babu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunil Babu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2019 | 1711 |
| 2 | Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome Hit paper breakdown → | 2013 | 1249 |
| 3 | Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial Hit paper breakdown → | 2022 | 517 |
| 4 | Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2020 | 516 |
| 5 | 2015 | 343 | |
| 6 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2023 | 240 |
| 7 | 2018 | 203 | |
| 8 | 2020 | 176 | |
| 9 | 2021 | 170 | |
| 10 | 2020 | 168 | |
| 11 | 2019 | 153 | |
| 12 | 2021 | 130 | |
| 13 | 2022 | 119 | |
| 14 | Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine Hit paper breakdown → | 2024 | 95 |
| 15 | 2017 | 90 | |
| 16 | 2017 | 89 | |
| 17 | 2022 | 72 | |
| 18 | 2017 | 62 | |
| 19 | 2020 | 49 | |
| 20 | 2021 | 48 |
About Sunil Babu
Sunil Babu is a scholar working on Genetics, Oncology, Hematology, Immunology and Pathology and Forensic Medicine, having authored 48 papers that have together received 6.5k indexed citations. Recurring topics across this work include Complement system in diseases (8 papers), Lymphoma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Lung Cancer Research Studies (4 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Oncology (3.1k citations), Nephrology (828 citations), Immunology (1.9k citations), Transplantation (187 citations) and Hematology (766 citations). Sunil Babu has collaborated with scholars based in United States, Canada and France. Frequent co-authors include David Robert Spigel, Jason Claud Chandler, Robert M. Jotte, Larry A. Greenbaum, Neil Sheerin, David J. Cohen, David Michael Waterhouse, Richard R. Furman, Christophe M. Legendre and Edward B. Garon. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.